Clinical Trial

A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a single-arm, non-randomized, open-label Phase 2 therapeutic study that will assess the effects of adding BPM31510 onto a conventional treatment framework of RT and concurrent TMZ chemotherapy for subjects with newly diagnosed glioblastoma.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2021-02-11; most recent amendment 2026-01-23.
Status change: Recruiting → Active, Not Recruiting 2025-09-03
Status change: Not Yet Recruiting → Recruiting 2021-08-30
Trial Details
NCT Number NCT04752813
Lead Sponsor BPGbio
Conditions Glioblastoma, Glioblastoma Multiforme
Enrollment 50 participants
Start Date 2022-08-22
Primary Completion 2026-08-25 (estimated)
Study Completion 2030-08-26 (estimated)
Updated on ClinicalTrials.gov 2026-01-26